ALZCUR.ST STO
AlzeCure Pharma AB
1W: -8.5%
1M: -15.7%
3M: -3.1%
YTD: +246.5%
1Y: +71.5%
3Y: +50.8%
5Y: -8.7%
kr 7.08 ($0.70)
+0.22 (+3.21%)
Weekly Expected Move ±5.7%
kr 6
kr 6
kr 7
kr 7
kr 8
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$59M
+71.5% ▲
5Y CAGR: -12.9%
Total Liabilities
$26M
+216.6% ▲
5Y CAGR: +29.9%
Shareholders Equity
$33M
+25.7% ▲
5Y CAGR: -21.5%
Cash & Investments
$50M
+59.8% ▲
5Y CAGR: -14.8%
Total Debt
$5M
+0.0% ▲
Net Debt
-$45M
-43.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $42M | $26M | $29M | $31M | $50M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $42M | $26M | $29M | $31M | $50M |
| Net Receivables | $2M | $2M | $3M | $3M | $5M |
| Inventory | -$2K | -$2K | $0 | $0 | $0 |
| Other Current Assets | -$919K | -$549K | -$1M | -$943K | $85K |
| Total Current Assets | $44M | $28M | $32M | $34M | $55M |
| Property, Plant & Equip. | $1M | $852K | $376K | $207K | $4M |
| Goodwill & Intangibles | $17K | $17K | $17K | $17K | $17K |
| Long-Term Investments | $7K | $7K | $0 | $0 | $0 |
| Other Non-Current Assets | $7K | $42M | $0 | $0 | -$1K |
| Total Non-Current Assets | $1M | $43M | $393K | $224K | $4M |
| Total Assets | $46M | $71M | $32M | $34M | $59M |
| — Liabilities — | |||||
| Accounts Payable | $6M | $5M | $3M | $3M | $4M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $319K | $333K | $3M | $314K | $19M |
| Total Current Liabilities | $13M | $10M | $8M | $8M | $24M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $3M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | -$3M |
| Total Non-Current Liabilities | $6M | $5M | $0 | $0 | $3M |
| Total Liabilities | $13M | $10M | $8M | $8M | $26M |
| — Equity — | |||||
| Common Stock | $944K | $1M | $2M | $2M | $3M |
| Retained Earnings | -$247M | -$303M | -$340M | -$375M | -$423M |
| Accumulated OCI | $0 | $284K | $0 | $0 | $0 |
| Total Stockholders Equity | $33M | $60M | $24M | $26M | $33M |
| Total Liabilities & Equity | $46M | $71M | $32M | $34M | $59M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $0 | $0 | $5M |
| Net Debt | -$42M | -$26M | -$29M | -$31M | -$45M |
| Total Investments | $7K | $7K | $0 | $0 | $0 |